Injective Integrates XRP via XRPL EVM Amid Rising Institutional Demand

Sean Williams
Injective (INJ)

Key Takeaways:

  • Injective becomes the first major blockchain to integrate XRPL EVM, onboarding XRP.
  • XRP trading volume jumped 114%, while INJ price dropped nearly 5% despite the integration news.
  • At least five companies are actively adopting XRP as a treasury asset, signaling rising institutional trust.

Injective, the interoperable layer-1 blockchain for finance, has taken a major leap forward by integrating XRP into its ecosystem via the XRP Ledger’s EVM Sidechain. This groundbreaking move positions Injective as the first major blockchain to connect with XRPL’s newly launched Ethereum-compatible network, opening doors for XRP to access advanced smart contract functionality.

Despite the milestone, Injective’s native token, INJ, has slipped nearly 5% today, reflecting broader market volatility.

XRPL EVM Sidechain Brings Ethereum Compatibility to XRP

The recent launch of the XRPL EVM Sidechain, developed by Peersyst in collaboration with Ripple, allows XRP to operate seamlessly within Ethereum’s smart contract environment. Injective’s live integration of this infrastructure is a pivotal step in unlocking on-chain finance use cases for XRP holders.

According to Injective’s announcement on X, the integration creates a “seamless gateway into one of the largest assets in all of crypto.” This development has already sparked positive price action for XRP, which surged as high as $2.319 before correcting to $2.19 — still posting a 1.13% gain in the past 24 hours. Trading volume soared 114%, hitting $4.14 billion.

INJ Price Declines Amid Broader Market Moves

While XRP gained momentum, INJ — Injective’s native asset — faced a sharp downturn. After peaking at $11.15 early Tuesday, INJ dropped to $10.42, down 4.9% on the day and 10% for the week. Its trading volume also saw a modest 4.5% dip, now hovering around $82.36 million. The price movement highlights the disconnect between strategic developments and short-term price action in the crypto market.

Institutional Momentum Builds Around XRP

Beyond Injective, a growing number of public companies are betting on XRP as a core treasury asset. Legal expert John Deaton recently revealed that at least five firms are implementing an XRP Treasury Strategy. These include:

  • Vivopower International, which raised $121 million toward a $100 million XRP treasury.
  • Hyperscale Data Inc., planning to launch an XRP lending platform.
  • Webus International, managing a $300 million XRP treasury for cross-border payments.
  • Wellgistics Health Inc., using XRP for real-time payments.
  • Worksport Ltd., also actively investing in XRP.

These moves suggest XRP is increasingly being seen not just as a utility token but as a viable financial asset on corporate balance sheets.

Also Read: Ripple and Web3 Salon Launch $200K Grants for XRPL Startups in Japan

Injective’s integration of XRP through the XRPL EVM Sidechain is a strategic leap for both ecosystems. While the INJ price faltered in the short term, the long-term implications for DeFi interoperability and XRP adoption are substantial. With public companies adopting XRP for treasury functions and new use cases emerging, the token is poised to play a larger role in institutional finance.

Disclaimer: The information in this article is for general purposes only and does not constitute financial advice. The author’s views are personal and may not reflect the views of Chain Affairs. Before making any investment decisions, you should always conduct your own research. Chain Affairs is not responsible for any financial losses.

Related Posts